Kodiak Sciences Inc - Common Stock (KOD)
2.6700
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 8:49 AM EDT
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
Via Chartmill · April 1, 2025

Via Benzinga · February 12, 2025

Via Benzinga · January 28, 2025

Kodiak Sciences Inc (NASDAQ: KOD)
Via Benzinga · November 6, 2023

Shares of Rumble Inc.
Via Benzinga · December 23, 2024

Via Benzinga · December 9, 2024

Via Benzinga · December 9, 2024

Jefferies upgrades Kodiak Sciences, citing undervaluation and growth potential as Phase 3 trials advance for tarcocimab in retinal diseases.
Via Benzinga · December 9, 2024

KOD stock results show that Kodiak Sciences beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 14, 2024

KOD stock results show that Kodiak Sciences beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 15, 2024

Via Benzinga · April 3, 2024

Via Benzinga · March 28, 2024

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.
Via Benzinga · March 28, 2024

KOD stock results show that Kodiak Sciences missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 28, 2024

U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday. Following the market opening Thursday, the Dow traded down 0.02% to 39,753.17 while the NASDAQ fell 0.08% to 16,385.80. The S&P 500 also rose, gaining, 0.04% to 5,250.38.
Via Benzinga · March 28, 2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via Benzinga · March 28, 2024

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.
Via Benzinga · December 11, 2023

Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
Via Benzinga · November 17, 2023

Via Benzinga · November 17, 2023

StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday.
Via Benzinga · November 13, 2023

We're starting off the trading week right with a breakdown of the biggest pre-market stock movers worth noting on Monday morning!
Via InvestorPlace · November 6, 2023

The Benzinga Stock Whisper Index uses proprietary data to look at stocks with increased interest from investors.
Via Benzinga · November 3, 2023